Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for NIACIN ER

See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for NIACIN ER (2017)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$14,587,968
INSIDE ANOTHER STORE	$8,171,876
[disabled in preview]	$39,008,683
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	28,189
INSIDE ANOTHER STORE	45,866
[disabled in preview]	198,237
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICARE	$37,206,013
OTHER PRIVATE	$2,395,794
[disabled in preview]	$22,166,720
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for NIACIN ER

Drug Units Sold Trends for NIACIN ER

Annual Sales Revenues and Units Sold for NIACIN ER

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Start Trial
Drug Name	Revenues (USD)	Units	Year
NIACIN ER	Start Trial	Start Trial	2017
NIACIN ER	Start Trial	Start Trial	2016
NIACIN ER	Start Trial	Start Trial	2015
NIACIN ER	Start Trial	Start Trial	2014
NIACIN ER	Start Trial	Start Trial	2013
NIACIN ER	Start Trial	Start Trial	2012
NIACIN ER	Start Trial	Start Trial	2011
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Boehringer Ingelheim

McKesson

Dow

Harvard Business School

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.